Panther Life Sciences Opens Next-Generation Microarray Patch (MAP) Platform to Pharma and Biotech Partners

NEW YORK, NY, UNITED STATES, January 6, 2026 / EINPresswire.com / — Panther Life Sciences announces expanded access to its ...
Medscape

Tissue Microarrays

With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
Scientific Research Publishing

Troyanskaya, O., Cantor, M., Sherlock, G., Brown, P., Hastie, T., Tibshirani, R., et al. (2001) Missing Value Estimation Methods for DNA Microarrays. Bioinformatics, 17, 520-525.

ABSTRACT: Attrition is a common challenge in statistical analysis for longitudinal or multi-stage cross-sectional studies. While strategies to reduce attrition should ideally be implemented during the ...
IEEE

Comprehensive Review of Hybrid Feature Selection Methods for Microarray-Based Cancer Detection

Abstract: Microarray data-based cancer detection advances early diagnosis and personalized medicine by utilizing gene expression data to develop comprehensive cancer profiles, measuring thousands of ...
GEN

Measuring Intact (Full-length, Capped, Tailed) mRNA in a Single Assay: 5′CapQ

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.
Scientific Research Publishing

Troyanskaya, O., Cantor, M., Sherlock, G., Brown, P., Hastie, T., Tibshirani, R., et al. (2001) Missing Value Estimation Methods for DNA Microarrays. Bioinformatics, 17, 520-525.

ABSTRACT: Missing data presents a significant challenge in statistical analysis and machine learning, often resulting in biased outcomes and diminished efficiency. This comprehensive review ...
BioSpace

DNA Microarray Market Size to Grow approximately USD 6.13 Bn by 2034

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
Frontiers

Multiplex detection and identification of viral, bacterial, and protozoan pathogens in human blood and plasma using an expanded high-density resequencing microarray platform

Introduction: Nucleic acid tests for blood donor screening have improved the safety of the blood supply; however, increasing numbers of emerging pathogen tests are burdensome. Multiplex testing ...